UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
F F F- F0 FA FB FC FD FE FF FG FH FI FJ FK FL FM FN FO FP FR FS FT FU FX FY
selected terms: 2,504 page 9 of 26

801. fertility promoting drug
[drugs used to increase fertility or to treat infertility in either males or females. ( CSP )] (UMLS (CSP) C0015896) =Pharmacologic Substance ;
=Drug;
=2-[p-(2-Chloro-1,2-diphenylvinyl)phenoxy]triethylamine;
851. FETAL BLOOD SAMPLE/BX
[ ] (UMLS (ICD9CM) C0177285) =Diagnostic Procedure
802. Fertility Study
(UMLS (NCI) C0200069) =Diagnostic Procedure
852. fetal cell culture
[ ] (UMLS (CSP) C0920515) fetus cell culture =Laboratory Procedure
803. FERTILITY TESTING
(UMLS (ICD9CM) C0886496) =Finding
853. FETAL DAMG D/T DRUG-UNSP
[ ] (UMLS (ICD9CM) C0157085) =Disease or Syndrome
804. Fertility/Fertilization
[fusion of a spermatozoan with an ovum resulting in the formation of a zygote. ( CSP )] (UMLS (NCI) C0015914) =Organism Function ;
=fecundity;
=in vitro Fertilization;
artificial fertilization
854. Fetal death from asphyxia or anoxia before onset of labor or at unspecified time
[ ] (UMLS (ICD9CM) C0270131) =Injury or Poisoning
805. Fertiral
(UMLS (NCI) C0591507) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
855. fetal diagnosis
[ ] (UMLS (CSP) C0599190) =Diagnostic Procedure ;
806. Ferumoxsil
[A silicon-coated iron oxide, and a superparamagnetic contrast agent used in magnetic resonance imaging (MRI). After oral administration, ferumoxsil moves through and occupies the stomach and intestines. During MRI, ferumoxsil generates T1 relaxation, producing a magnetic field and enhancing T2 relaxation, thereby darkening contrast media-containing structures. This allows visualization of adjacent abdominal tissues. ( NCI )] (UMLS (NCI) C0257928) =Indicator, Reagent, or Diagnostic Aid; Inorganic Chemical =oxide;
siloxane;
[TN401] IRON;
[DX900] DIAGNOSTICS, OTHER =ferumoxsil 0.175 MG/ML
856. FETAL DISPRO NOS-ANTEPAR
[ ] (UMLS (ICD9CM) C0156987) =Disease or Syndrome ;
807. Ferumoxtran-10
[A synthetic ultrasmall superparamagnetic iron oxide composed of dextran-coated iron oxide nanoparticles (also known as 'ultrasmall particulate iron oxides' or USPIO). Ferumoxtran-10, which accumulates in non-cancerous lymphatic tissue, is used as a molecular resonance imaging (MRI) contrast agent. (NCI04) ( NCI )] (UMLS (NCI) C0386370) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
857. FETAL DISPROP NOS-DELIV
[ ] (UMLS (ICD9CM) C0156986) =Disease or Syndrome ;
808. Ferumoxytol
[A superparamagnetic iron oxide nanoparticle coated with a low molecular weight semi-synthetic carbohydrate, polyglucose sorbitol carboxymethyl ether, with potential anti-anemic and imaging properties. After intravenous administration, ferumoxytol replaces iron stores with fewer side effects compared to the use of oral iron. In addition, this agent generates T1 relaxation, producing a magnetic field and enhancing T2 relaxation, thereby darkening contrast media-containing structures in magnetic resonance imaging (MRI). Due to small particle size, ferumoxytol remains in the intravasculature for a prolonged period and so may be used as a blood pool agent. (NCI05) ( NCI )] (UMLS (NCI) C1453192) =Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid
858. FETAL DISPROP NOS-UNSPEC
[ ] (UMLS (ICD9CM) C0156985) =Disease or Syndrome ;
809. FES
[Human Oncogene FPS-FES is a mutated variant of FES Gene (FES/FPS Subfamily), which encodes 822 aa 93-kDa Tyrosine-Protein Kinase FES/FPS, a tyrosine-specific protein kinase involved in normal hematopoiesis and containing an FCH and SH2 domain. The FES chromosomal location is linked to a translocation identified in patients with acute promyelocytic leukemia. A truncated transcript is generated utilizing a start site in a far downstream exon. Oncogene FPS-FES disrupts normal cell function. ( NCI )] (UMLS (NCI) C0812383) FPS;
Fujinami Sarcoma Virus and Feline Sarcoma Virus Transforming Gene;
Oncogene FES;
Oncogene FPS-FES =Gene or Genome ;
859. Fetal distress affecting management of mother
(UMLS (ICD9CM) C0015931) =Disease or Syndrome ;
810. FET DAMAG D/T DRUG-DELIV
[ ] (UMLS (ICD9CM) C0157086) =Disease or Syndrome
860. Fetal distress first noted during labor and delivery, in liveborn infant
[ ] (UMLS (ICD9CM) C1719625) FETAL DISTRS DUR LAB/DEL =Pathologic Function
811. FET DAMG D/T DIS-ANTEPAR
[ ] (UMLS (ICD9CM) C0157083) =Disease or Syndrome
861. FETAL DISTRESS NOS
[ ] (UMLS (ICD9CM) C0270124) =Disease or Syndrome
812. FET DAMG D/T DIS-DELIVER
[ ] (UMLS (ICD9CM) C0157082) =Disease or Syndrome
862. Fetal distress, affecting management of mother, antepartum
[ ] (UMLS (ICD9CM) C0157114) =Disease or Syndrome
813. FET DAMG D/T DIS-UNSPEC
[ ] (UMLS (ICD9CM) C0157081) =Disease or Syndrome
863. Fetal distress, affecting management of mother, delivered
[ ] (UMLS (ICD9CM) C0157113) =Disease or Syndrome
814. FET DAMG D/T DRUG-ANTEPA
[ ] (UMLS (ICD9CM) C0157087) =Disease or Syndrome
864. Fetal distress, affecting management of mother, unspecified as to episode of care
[ ] (UMLS (ICD9CM) C0157112) =Disease or Syndrome
815. FET DAMG D/T VIRUS-ANTEP
[ ] (UMLS (ICD9CM) C0157079) =Disease or Syndrome
865. FETAL EKG
[ ] (UMLS (ICD9CM) C0177284) =Diagnostic Procedure
816. FET DAMG D/T VIRUS-DELIV
[ ] (UMLS (ICD9CM) C0157078) =Disease or Syndrome
866. Fetal Heart
[The heart of the fetus of any viviparous animal. It refers to the heart in the postembryonic period and is differentiated from the embryonic heart (HEART/embryology) only on the basis of time. ( MSH )] (UMLS (NCI) C0015935) =Embryonic Structure ;
817. FET DAMG D/T VIRUS-UNSP
[ ] (UMLS (ICD9CM) C0157077) =Disease or Syndrome
867. fetal hemoglobin
[fetal hemoglobin; major component of hemoglobin in the fetus; it has two alpha and two gamma polypeptide subunits in comparison to normal adult hemoglobin, which has two alpha and two beta polypeptide subunits. ( CSP )] (UMLS (CSP) C0015936) =Amino Acid, Peptide, or Protein; Biologically Active Substance =hemoglobin;
embryo/fetus protein
818. FET DEATH-ANOXIA DUR LAB
[ ] (UMLS (ICD9CM) C0158928) =Pathologic Function
868. fetal hypoxia
[Hypoxia in utero, caused by conditions such as inadequate placental function (often abruptio placentae), preeclamptic toxicity, prolapse of the umbilical cord, or complications from anesthetic administration. ( NCI )] (UMLS (CSP) C0349489) =Disease or Syndrome
819. FET DISTRESS BEFOR LABOR
[ ] (UMLS (ICD9CM) C0158929) =Pathologic Function
869. fetal infection
[ ] (UMLS (CSP) C1397629) =Disease or Syndrome
820. FET GROWTH RET 2500+G
[ ] (UMLS (ICD9CM) C0158891) =Disease or Syndrome
870. Fetal Lipomatosis
[A benign disorder characterized by the presence of multiple lipoblastomas. ( NCI )] (UMLS (NCI) C0334475) =Neoplastic Process
821. FET GROWTH RET 500-749G
[ ] (UMLS (ICD9CM) C0158884) =Disease or Syndrome
871. fetal macrosomatia
[ ] (UMLS (CSP) C0599193) =Congenital Abnormality; Disease or Syndrome
822. FET GROWTH RET 750-999G
[ ] (UMLS (ICD9CM) C0158885) =Disease or Syndrome
872. fetal macrosomia
[A condition of fetal overgrowth leading to a large-for-gestational-age FETUS. It is defined as BIRTH WEIGHT greater than 4,000 grams or above the 90th percentile for population and sex-specific growth curves. It is commonly seen in GESTATIONAL DIABETES; PROLONGED PREGNANCY; and pregnancies complicated by pre-existing diabetes mellitus. ( MSH )] (UMLS (CSP) C0015938) =Disease or Syndrome ;
=embryo/fetus disorder;
Diabetes mellitus, antepartum;
Diabetes in Pregnancy;
823. FET GROWTH RETARD
[ ] (UMLS (ICD9CM) C0158883) =Disease or Syndrome
873. FETAL MAL 1000-1249G
[ ] (UMLS (ICD9CM) C0158876) =Disease or Syndrome
824. FET GROWTH RETARD WTNOS
[abnormal fetal physical growth or growth potential at any gestational stage. ( CSP )] (UMLS (ICD9CM) C0015934) =Pathologic Function ;
=embryo/fetus disorder;
Growth Disorders;
developmental disease/disorder;
874. FETAL MAL 1250-1499G
[ ] (UMLS (ICD9CM) C0158877) =Disease or Syndrome
825. FET GRWTH RET 1000-1249G
[ ] (UMLS (ICD9CM) C0158886) =Disease or Syndrome
875. FETAL MAL 1500-1749G
[ ] (UMLS (ICD9CM) C0158878) =Disease or Syndrome
826. FET GRWTH RET 1250-1499G
[ ] (UMLS (ICD9CM) C0158887) =Disease or Syndrome
876. FETAL MAL 750-999G
[ ] (UMLS (ICD9CM) C0158875) =Disease or Syndrome
827. FET GRWTH RET 1500-1749G
[ ] (UMLS (ICD9CM) C0158888) =Disease or Syndrome
877. FETAL MALNUTR 1750-1999G
[ ] (UMLS (ICD9CM) C0158879) =Disease or Syndrome
828. FET GRWTH RET 1750-1999G
[ ] (UMLS (ICD9CM) C0158889) =Disease or Syndrome
878. FETAL MALNUTR 2000-2499G
[ ] (UMLS (ICD9CM) C0158880) =Disease or Syndrome
829. FET GRWTH RET 2000-2499G
[ ] (UMLS (ICD9CM) C0158890) =Disease or Syndrome
879. FETAL MALNUTR 2500+G
[ ] (UMLS (ICD9CM) C0158881) =Disease or Syndrome
830. FET/PLAC PROB NEC-ANTEPA
[ ] (UMLS (ICD9CM) C0157133) =Disease or Syndrome
880. FETAL MALNUTR 500-749G
[ ] (UMLS (ICD9CM) C0158874) =Disease or Syndrome
831. FET/PLAC PROB NEC-DELIV
[ ] (UMLS (ICD9CM) C0157132) =Disease or Syndrome
881. FETAL MALNUTRITION
[ ] (UMLS (ICD9CM) C0158873) =Disease or Syndrome
832. FET/PLAC PROB NEC-UNSPEC
[ ] (UMLS (ICD9CM) C0157131) =Disease or Syndrome
882. Fetal malnutrition without mention of "light-for-dates"
[ ] (UMLS (ICD9CM) C1510504) =Disease or Syndrome ;
833. FET/PLAC PROB NOS-ANTEPA
[ ] (UMLS (ICD9CM) C0157137) =Disease or Syndrome
883. Fetal malnutrition without mention of "light-for-dates", unspecified [weight]
[ ] (UMLS (ICD9CM) C0158872) =Disease or Syndrome
834. FET/PLAC PROB NOS-DELIV
[ ] (UMLS (ICD9CM) C0157136) =Disease or Syndrome
884. fetal monitoring
[Physiologic or biochemical monitoring of the fetus. It is usually done during LABOR, OBSTETRIC and may be performed in conjunction with the monitoring of uterine activity. It may also be performed prenatally as when the mother is undergoing surgery. ( MSH )] (UMLS (CSP) C0015945) =Diagnostic Procedure
835. FET/PLAC PROB NOS-UNSPEC
[ ] (UMLS (ICD9CM) C0157135) =Disease or Syndrome
885. fetal neoplasm
[ ] (UMLS (CSP) C0598366) =Neoplastic Process ;
836. fetal
[ ] (UMLS (CSP) C0521457) =Functional Concept
886. fetal nutrition
[ ] (UMLS (CSP) C0598900) =Organism Attribute ;
837. Fetal
[(FEET-us) The developing offspring from 7 to 8 weeks after conception until birth. ( NCI )] (UMLS (NCI) C0015965) =Embryonic Structure =Body Part;
887. FETAL OPS-FACILITATE DEL
(UMLS (ICD9CM) C0846357) Operations on fetus to facilitate delivery;
=Therapeutic or Preventive Procedure
838. FETAL & NEWBORN ASP NOS
[ ] (UMLS (ICD9CM) C1561791) Fetal and newborn aspiration, unspecified;
=Pathologic Function
888. fetal protein
[ ] (UMLS (CSP) C0015950) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
839. Fetal -Epithelial Differentiation
(UMLS (NCI) C1333607) =Finding
889. FETAL PULSE OXIMETRY
[ ] (UMLS (ICD9CM) C0994541) =Diagnostic Procedure
840. FETAL ABNORM NEC-ANTEPAR
[ ] (UMLS (ICD9CM) C0157095) =Disease or Syndrome
890. Fetal Rhabdomyoma
[A rare benign mesenchymal neoplasm arising from skeletal muscle. It is characterized by the presence of immature spindle and polygonal cells within a scant myxoid stroma. It usually develops in the head and neck region of young children. ( NCI )] (UMLS (NCI) C0334482) =Neoplastic Process
841. FETAL ABNORM NEC-DELIVER
[ ] (UMLS (ICD9CM) C0157094) =Disease or Syndrome
891. fetal rickets
[ ] (UMLS (CSP) C0242080) =Disease or Syndrome
842. FETAL ABNORM NEC-UNSPEC
[ ] (UMLS (ICD9CM) C0157093) =Disease or Syndrome
892. fetal stress
[ ] (UMLS (CSP) C0456057) =Pathologic Function =stress;
843. FETAL ABNORM NOS-ANTEPAR
[ ] (UMLS (ICD9CM) C0157099) =Disease or Syndrome
893. fetal surgery
[ ] (UMLS (CSP) C1261465) fetus surgery;
=Therapeutic or Preventive Procedure ;
844. FETAL ABNORM NOS-DELIVER
[ ] (UMLS (ICD9CM) C0157098) =Disease or Syndrome
894. fetal tissue
[Any tissue from a fetus. ( NCI )] (UMLS (CSP) C0242291) =Tissue
845. FETAL ABNORM NOS-UNSPEC
[ ] (UMLS (ICD9CM) C0157097) =Disease or Syndrome
895. fetal tissue transplantation
[Transference of fetal tissue between individuals of the same species or between individuals of different species. ( MSH )] (UMLS (CSP) C0079345) =Therapeutic or Preventive Procedure ;
846. Fetal Adenoma
[A thyroid gland adenoma composed of microfollicular structures. (NCI05) ( NCI )] (UMLS (NCI) C0334328) =Neoplastic Process
896. FETAL-MATERN HEM-ANTEPAR
[ ] (UMLS (ICD9CM) C0157104) =Disease or Syndrome
847. Fetal and neonatal hemorrhage
[ ] (UMLS (ICD9CM) C0473800) =Pathologic Function
897. FETAL-MATERNAL HEM-DELIV
[ ] (UMLS (ICD9CM) C0157103) =Disease or Syndrome
848. Fetal and newborn aspiration
[ ] (UMLS (ICD9CM) C1561805) =Pathologic Function
898. Fetal-maternal hemorrhage affecting management of mother
[ ] (UMLS (ICD9CM) C0157101) =Disease or Syndrome
849. fetal blood
[Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery. ( MSH )] (UMLS (CSP) C0015925) =Tissue ;
899. Fetal-maternal hemorrhage, unspecified as to episode of care in pregnancy
[Transplacental passage of fetal blood into the circulation of the maternal organism. (Dorland, 27th ed) ( MSH )] (UMLS (ICD9CM) C0015959) =Pathologic Function =Anemia, Neonatal;
850. Fetal blood loss
[ ] (UMLS (ICD9CM) C0158951) =Disease or Syndrome ;
900. FETAL/NEONATAL HEPATITIS
[ ] (UMLS (ICD9CM) C0158976) =Disease or Syndrome ;

Buy website

Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.
Affordable prices from $100.

 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM